JPRN-UMIN000044687
Recruiting
未知
Evaluation and prevention of diabetic osteosarcopenia in the elderly by nutritional intervention and physical activity advice: DOS study ( Diabetic OsteoSarcopenia study in the elderly): an open, single-arm, prospective, interventional study. - DOS study
Fujita Health University School of Medicine Department of Endocrinology, Diabetes and Metabolism0 sites80 target enrollmentStarted: June 28, 2021Last updated:
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Fujita Health University School of Medicine Department of Endocrinology, Diabetes and Metabolism
- Enrollment
- 80
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 75years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients with obvious dementia or mental illness. (2\) Patients using steroids. (3\) Patients with hepatic disorder with a Child\-Pugh classification of 7 points or higher, or renal dysfunction with a serum creatinine level of 2 mg / dL or higher. (4\) Heart failure with restricted physical activity (NYHA classification II or higher). (5\) Patients with significant chronic complications of diabetes (nephrosis, active proliferative retinopathy, severe autonomic neuropathy). (6\) Patients with an infectious disease corresponding to SIRS (systemic inflammatory response syndrome) or trauma with an AIS (abbreviated injury scale) score of 4 or higher. (7\) Patients who are judged to have incurable cancer. (8\) Patients with a cardiac pacemaker or implantable cardioverter\-defibrillator, etc. (9\) Patients with motor paralysis of limbs due to central nervous system disease. (10\) Patients who are judged to be inappropriate for this clinical study by the person in charge of research or the research coordinator.
Investigators
Similar Trials
Completed
Not Applicable
Clinical research on the risk factors of Sarcopenia in diabetic patientsDiabetes, Sarcopenia, DynapeniaJPRN-UMIN000020901Tokushima University1,328
Completed
Not Applicable
Sarcopenia and Diabetes MellitusSarcopeniaNCT04407819Dionyssiotis, Yannis, M.D.50
Unknown
Phase 4
A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover MarkersOsteoporosisDiabetes MellitusNCT02429232National Taiwan University Hospital160
Active, not recruiting
Not Applicable
Early Prevention of Diabetes Complications in people with Pre-Diabetes in Europeon diabetic hyperglycaemia:Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) or bothMedDRA version: 17.1Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-000418-39-ESFUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES CARDIOVASCULARES (FIRCAVA)3,000
Active, not recruiting
Not Applicable
Early Prevention of Diabetes Complications in people with Pre-Diabetes in Europeon diabetic hyperglycaemia:Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) or bothMedDRA version: 17.1Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-000418-39-ATFUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES3,000